Skip to main content

Correction: Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements

The Original Article was published on 26 October 2021

Correction: BMC Neurol 21, 410 (2021)

https://doi.org/10.1186/s12883-021-02450-y

Following publication of the original article [1], an error was identified in the Appendix section, List of Delphi Panel members.

The updated appendix is given below and the changes have been highlighted in bold.

Appendix

List of Delphi Panel members

Umberto Oscar Aguglia (Ospedali Riuniti, Reggio Calabria), Francesca Anzellotti (Ospedale SS Annunziata, Chieti), Carla Arbassino (Ospedale Salesi, Ancona), Daniela Audenino (Ospedale Galliera, Genova), Valeria Badioni (UO Universita di Milano), Irene Bagnasco (Ospedale Martini, Torino), Emanuele Bartolini (Nuovo Ospedale S. Stefano, Prato), Yerma Bartolini (Ospedale Bufalini, Cesena), Vincenzo Belcastro (Ospedale S. Anna, Como), Patrizia Bergonzini (Policlinico NPI, Modena), Pia Bernardo (Univ. Della Campania Luigi Vanvitelli, Napoli), Giovanni Boero (Ospedale Centrale SS Annunziata, Taranto), Alice Bonuccelli (Ospedale Santa Chiara, Pisa), Francesco brigo (Ospedale Tappeiner, Merano), Gaetano Cantalupo (Ospedale Maggiore Borgo Trento, Verona), Giuseppe Ceres (ASL, Salerno), Caterina Cerminara (Policlinico Tor Vergata, Roma), Valentina Chiesa (Ospedale San Paolo, Milano), Antonietta Coppola (Universita Federico II, Napoli), Duccio Maria Cordelli (Policlinico Sant’Orsola, Bologna), Autilia Cozzolino (Ospedale Giuseppe Moscati, Avellino), Barbara Cruciatti (Ospedale Civile, Pordenone), Valentina De Giorgis (Istituto Neurologico Mondino, Pavia), Giovanni De Maria (Spedali Civili, Brescia), Fernando De Paolis (Ospedale Santa Caterina Novella, Galatina), Roberto De Simone (Policlinico Sant’Eugenio, Roma), Francesco Deleo, (IRCCS Istituto Besta, Milano), Giuseppe D’Orsi (Ospedali Riuniti, Foggia), Vania Durante (pres. Brindisi Di Summa-Perrino, Brindisi), Raffaella Fagioli (Ospedale, Cona, Ferrara), Elisa Fallica (Ospedale, Cona, Ferrara), Elena Freri (IRCCS Istituto Besta, Milano), Alfonso Giordano (Univ. della Campania Luigi Vanvitelli, Napoli), Loretta Giuliano (Pres. Ospedaliero Gaspare Rodolico, Catania), Shalom Haggiag (Ospedale San Camillo, Roma), Francesca Izzi (AOU Tor Vergata, Roma), Angela La Neve (Ospedale Consorziale Policlinico, Bari), Emilio Le Piane (Ospedale Pugliese, Catanzaro), Concetta Luisi (Policlinico Ospedaliero, Padova), Greta Marcorig (Ospedale Civile, Gorizia), Carlo Alberto Mariani (ASP, Palermo), Carla Marini (Ospedale Salesi, Ancona), Alfonso Marrelli (Osp. Reg, S, Salvatore, L’Aquila), Marta Maschio (Center for Tumor Epilepsy, UOSD Neuroncologia IRCCS Regina Elena, Rome), Roberto Michelucci (Ospedale Bellaria, Bologna), Fabio Minicucci (IRCCS San Raffaele, Milano), Antonio Modica (ARNAS Civico Di Cristina, Palermo), Maurizio Montalto (AO Riuniti Villa Sofia Cervello, Palermo), Francesca Muzzi (Policlinico Grassi, Ostia, Roma), Rosaria Nardello (Policlinico, Univ. Giaccone, Palermo), Alessandro Orsini (Ospedale Santa Chiara, Pisa), Nicola Paciello (Ospedale San Carlo, Potenza), Mariangela Panebianco (Opsedale Garibaldi, Catania), Irene Pappalardo (Ospedale San Martino, Genova), Daniela Passarelli (Ospedale, Faenza, Ravenna), Giada Pauletto (Ospedale S.M. Misericordia, Udine), Piero Penza (AOU Ruggi D’Aragona, Salerno), Gabriella Perri (Ospedale Salvini Rhodense, Garbagnate, Milano), Marianna Pezzella (Ospedale Cardarelli, Napoli), Piero Pignatta (Ospedale Gradenigo, Torino), Dario Pruna (AO Brotzu, Cagliari), Stefano Quadri (Ospedale Giovanni XXIII, Bergamo), Rosaria Renna (AORN Cardarelli, Napoli), Sara Renzi (Ospedale Madonna del Soccorso, Ascoli), Paolo Ricciardelli (Ospedale, Faenza, Ravenna), Romana Rizzi (AO Santa Maria Nuova, Reggio Emilia), Angelo Russo (Ospedale Bellaria NPI, Bologna), Nicola Sciscio (Centro Australia, Avellino), Vittorio Sciruicchio (Policlinico San Paolo, Bari), Carlotta Spagnoli (AO Santa Caterina Nuova, Reggio Emilia), Orazio Spitaleri (Pres. Osp. S. Marta S. Venera, Acireale, Catania), Pasquale Striano (Istituto Gaslini, Genova), Elena Tartara (Istituto Neurologico Mondino, Pavia), Lidia Urso (AO Sant’Antonio Abate, Erice, Trapani), Anna Vaudano (Ospedale, Baggiovara, Modena), Pierangelo Veggiotti (Ospedale Buzzi, Milano), Fabiana Vercellino (Ospedale San Biagio, Alessandria), Maurizio Viri (Ospedale Maggiore, Novara), Roberta Vittorini (OIRM Regina Margherita, Torino), Cristina Zammarchi (Ospedale Infermi, Rimini), Clara Zanchi (Ospedale, Seriate, Bergamo), Tiziano Zanoni (Osp. Borgo Trento, Verona), Lucia Zinno (Ospedale Maggiore, Parma), Leila Zummo (ARNAS Civico Di Caterina, Palermo), Nicoletta Foschi (Ospedale Torrette, Ancona).

The original article [1] has been updated.

Reference

  1. Bonanni P, Gambardella A, Tinuper P, et al. Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements. BMC Neurol. 2021;21:410. https://doi.org/10.1186/s12883-021-02450-y.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paolo Bonanni.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bonanni, P., Gambardella, A., Tinuper, P. et al. Correction: Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements. BMC Neurol 22, 184 (2022). https://doi.org/10.1186/s12883-022-02701-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12883-022-02701-6